R&D channel feed – Endpoints News

R&D channel feed

FDA approves Sanofi's RNAi drug for hemophilia A and B

3 months ago

BioNTech details promising mid-stage data for its PD-L1xVEGF in aggressive lung cancer

3 months ago

Merck KGaA pays Abbisko $85M for full commercial rights to benign tumor drug

3 months ago

Merck details injectable Keytruda data as it awaits autumn FDA decision

3 months ago

Equillium says graft-versus-host drug fails Phase 3, stock dives

3 months ago

Candel to focus on non-squamous lung cancer following new survival data

3 months ago

FDA approves first drug for Prader-Willi syndrome, to tamp down insatiable hunger symptoms

3 months ago

Exelixis’ primary cancer drug wins FDA approval for neuroendocrine tumors

3 months ago

Small biotech joins list of health companies taking a trip to Trump's Mar-a-Lago

3 months ago

J&J touts new survival data pitting lung cancer combo against AstraZeneca's rival

3 months ago

Wave strengthens case for accelerated approval, with more positive Duchenne data

3 months ago

The Endpoints Slack interview: Duke’s Pranam Chatterjee unpacks AI bio’s pretty picture fallacy

3 months ago

Epicrispr raises $68M, will start clinical trial of epigenetic editing for FSHD

3 months ago

Senate confirms Makary as FDA chief with agency cuts, return-to-office in force

3 months ago

Axsome reports Phase 3 win for Sunosi in adults with ADHD, with a high-dose caveat

3 months ago

Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

3 months ago

Kezar toplines small Phase 2a dataset in autoimmune liver disease

3 months ago

GSK to research whether shingles vaccine can cut dementia risk

3 months ago

FDA's biologics chief stresses need for vaccine transmission data despite high costs to generate

3 months ago

Two biotechs fail to beat or match Regeneron's Eylea in key trials

3 months ago

Novo Nordisk pays $200M upfront for China-based biotech’s triple-G obesity shot

3 months ago

Biogen plans to open new headquarters in Boston area in 2028

3 months ago

AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China

3 months ago

CDC vaccine meeting, delayed earlier this year, is rescheduled

3 months ago

First page Previous page 9 10 111213 14 15 Next page Last page